Tivanisiran sodium ophthalmic solution ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

53. シェーグレン症候群

---

臨床試験数 : 305 /  薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04819269 (ClinicalTrials.gov)	May 25, 2021	24/3/2021	Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome	Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome	Dry Eye Disease;Sjögren Syndrome	Drug: Tivanisiran sodium ophthalmic solution;Drug: Vehicle ophthalmic solution	Sylentis, S.A.	NULL	Recruiting	18 Years	N/A	All	200	Phase 3	United States;Spain